Literature DB >> 9549804

Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions.

E A Hahn1, K A Webster, D Cella, D L Fairclough.   

Abstract

Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi-centre clinical trials has led to innovative strategies for protocol design and high quality data collection. A scientific advisory committee reviews protocol design components, measurement selection, timing of assessments and compliance issues. Extensive educational programmes provide information about the scientific and clinical relevance of QOL protocols, as well as practical strategies for data collection and management. Compliance with QOL data collection standards is prospectively monitored and evaluated. Preliminary results from eight ECOG-run protocols found overall compliance to be approximately 85 per cent (94 per cent at baseline and 73 per cent during treatment). Selected patient and institutional factors were evaluated for their association with compliance.

Entities:  

Mesh:

Year:  1998        PMID: 9549804     DOI: 10.1002/(sici)1097-0258(19980315/15)17:5/7<547::aid-sim802>3.0.co;2-f

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Response and non-response to a quality-of-life question on sexual life: a case study of the simple mean imputation method.

Authors:  Yin Bun Cheung; Rhian Daniel; Gim Yew Ng
Journal:  Qual Life Res       Date:  2006-05-27       Impact factor: 4.147

2.  Proxy ratings of health related quality of life in patients with hepatocellular carcinoma.

Authors:  Jennifer L Steel; David A Geller; Brian I Carr
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

3.  Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial.

Authors:  C M Moinpour; B Lyons; P K Grevstad; L C Lovato; J Crowley; K Czaplicki; Z M Buckner; P A Ganz; K Kelly; D R Gandara
Journal:  Qual Life Res       Date:  2002-03       Impact factor: 4.147

4.  Pain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trials.

Authors:  Donald W Robinson; Ning Zhao; Fitzroy Dawkins; Ming Qi; Dennis Revicki
Journal:  Qual Life Res       Date:  2013-04-16       Impact factor: 4.147

5.  Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer.

Authors:  Patricia J Hollen; Richard J Gralla; Cynthia N Rittenberg
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

6.  The need for education on health related-quality of life.

Authors:  Melanie J Calvert; John R Skelton
Journal:  BMC Med Educ       Date:  2008-01-14       Impact factor: 2.463

Review 7.  Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review.

Authors:  Rebecca Mercieca-Bebber; Michael J Palmer; Michael Brundage; Melanie Calvert; Martin R Stockler; Madeleine T King
Journal:  BMJ Open       Date:  2016-06-15       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.